Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Diseases × Ibuprofen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Pain 3 Cachexia 3 Breast Neoplasms 3 Trigger Finger Disorder 2 Lung Neoplasms 2 Inflammation 2 Ganglion Cysts 2 De Quervain Disease 2 Colorectal Neoplasms 2 Weight Loss 1 Supratentorial Brain Tumor 1 Stomach Neoplasms 1 Prostatitis 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pituitary Neoplasms 1 Patient Satisfaction 1 Pancreatic Neoplasms 1 Mucositis 1 Menorrhagia 1 Median Neuropathy 1 Mastocytosis, Systemic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Hairy Cell 1 Leiomyoma 1 Kidney Neoplasms 1 Hodgkin Disease 1 Hemorrhage 1

Interventions

Letrozole 5 pyrotinib 4 Trastuzumab 4 Anastrozole 4 palbociclib 3 exemestane 2 abemaciclib 2 Sodium Chloride 2 Exercise 2 Epirubicin 2 Drug Evaluation 2 Docetaxel 2 Cyclophosphamide 2 Botulinum Toxins, Type A 2 Blood Specimen Collection 2 Aromatase Inhibitors 2 sacubitril and valsartan sodium hydrate drug combination 1 ribociclib 1 pertuzumab 1 gadoterate meglumine 1 Vinorelbine 1 Tomography, X-Ray Computed 1 Tamoxifen 1 Surveys and Questionnaires 1 Surgimend 1 Surgical Procedures, Operative 1 Paclitaxel 1 Mammaplasty 1 Liquid Biopsy 1 Leflunomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00299039 2009-02-02

T3AI

Nova Scotia Health Authority

Phase 3 Completed

Agnosia, Breast Diseases, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡